IMGN | ImmunoGen, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	31.22 - 31.25
52 Week Range	3.61 - 31.25
Beta	1.06
Implied Volatility	51.93%
IV Rank	0.41%
Day's Volume	19,311,442
Average Volume	8,287,745
Shares Outstanding	279,353,984
Market Cap	8,725,621,690
Sector	Healthcare
Industry	Biotechnology
IPO Date	1989-11-17

Valuation
Profitability
Growth
Health
P/E Ratio	-111.55
Forward P/E Ratio	N/A
EPS	-0.28
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	277
Country	USA
Website	IMGN

ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sunirine, a CD123-targeting ADC that is in Phase II clinical trial for treating acute myeloid leukemia and blastic plasmacytoid dendritic cell neoplasm. Its preclinical programs include IMGC936, an ADC in co-development with MacroGenics, Inc.; and IMGN151, an anti FRa product candidate. The company has collaborations with Roche; Amgen/Oxford BioTherapeutics; Bayer HealthCare AG; Eli Lilly and Company; Novartis Institutes for BioMedical Research, Inc.; CytomX Therapeutics, Inc.; Fusion Pharmaceuticals Inc.; Debiopharm International SA; and MacroGenics, Inc. ImmunoGen, Inc. was founded in 1980 and is headquartered in Waltham, Massachusetts.

IMGN's peers: ADAP, ATNM, AUPH, AXSM, BGNE, CPRX, INCY, INKT, MNKD, PLX, REGN, SGMO, VERU, VKTX

*Chart delayed

Analyzing fundamentals for IMGN we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is moderate, Growth is on medium level and Health is passable. For more detailed analysis please see IMGN Fundamentals page.

Watching at IMGN technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on IMGN Technicals page.